Grant: DRA: Canada Impact+ Research Training Awards - Doctoral
University of Guelph
$120,000.00
Development of treatment for brain cancer
EF 2025-26
Résumé
"Immunotherapy enables the body's defense system to identify and selectively attack cancer. Immunotherapy has been successfully used to treat many cancer types, although it has shown limited success for deadly brain cancers that lack cytotoxic T cells within the tumor. The immune system functions best at recognizing tumors when an alarm signal is released by dying tumor cells. Stressed and dying cancer cells send messages to educate immune cells that danger is apparent. Certain types of tumor cell death can wake up the immune system; however, it remains unknown which type of cell death and downstream processes make tumor cell death immune-stimulatory.
Our CIHR-funded research shows that a type of fiery cancer cell death, called pyroptosis, reignites anti-cancer immunity to fight off glioblastoma brain tumors, and we are seeing impressive cures in some of the treated mice. The doctoral student supported by the Canada Impact+ will work on developing a novel RNA therapeutic platform to activate pyroptosis in brain tumors derived from human patients. Successful completion of the project will provide the foundational knowledge required to develop new safe and effective treatments for cancer patients diagnosed with immunotherapy-refractory brain cancers."
Programme
DRA: Canada Impact+ Research Training Awards - Doctoral
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
568181
Name
Awigchew Liyuwork T
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Canada Impact+ Research Training Awards - Doctoral
Projecttitle
Development of treatment for brain cancer
Programtype2
Studentship Programs
Orgnameinp2
University of Guelph
Cihramount2
$120,000
Cihrequipment2
$0
Programname2
DRA: Canada Impact+ Research Training Awards - Doctoral
Keyworddelim
Brain Cancer; Cell Death; Immunotherapy
Abstract
"Immunotherapy enables the body's defense system to identify and selectively attack cancer. Immunotherapy has been successfully used to treat many cancer types, although it has shown limited success for deadly brain cancers that lack cytotoxic T cells within the tumor. The immune system functions best at recognizing tumors when an alarm signal is released by dying tumor cells. Stressed and dying cancer cells send messages to educate immune cells that danger is apparent. Certain types of tumor cell death can wake up the immune system; however, it remains unknown which type of cell death and downstream processes make tumor cell death immune-stimulatory.
Our CIHR-funded research shows that a type of fiery cancer cell death, called pyroptosis, reignites anti-cancer immunity to fight off glioblastoma brain tumors, and we are seeing impressive cures in some of the treated mice. The doctoral student supported by the Canada Impact+ will work on developing a novel RNA therapeutic platform to activate pyroptosis in brain tumors derived from human patients. Successful completion of the project will provide the foundational knowledge required to develop new safe and effective treatments for cancer patients diagnosed with immunotherapy-refractory brain cancers."
Competitiondate
202603
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Awigchew, Liyuwork T
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $120,000~ $0~